SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.608
AS - Asia 15.988
EU - Europa 8.768
SA - Sud America 2.354
Continente sconosciuto - Info sul continente non disponibili 517
AF - Africa 341
OC - Oceania 31
Totale 63.607
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.856
SG - Singapore 6.028
CN - Cina 3.944
DE - Germania 1.809
BR - Brasile 1.796
VN - Vietnam 1.777
IT - Italia 1.514
UA - Ucraina 1.469
HK - Hong Kong 1.235
GB - Regno Unito 980
TR - Turchia 957
FI - Finlandia 768
BD - Bangladesh 544
FR - Francia 541
SE - Svezia 436
RU - Federazione Russa 416
CA - Canada 407
JP - Giappone 357
IN - India 312
PL - Polonia 218
MX - Messico 217
AR - Argentina 196
ID - Indonesia 181
NL - Olanda 124
IQ - Iraq 122
ZA - Sudafrica 121
BE - Belgio 91
EC - Ecuador 91
ES - Italia 82
PK - Pakistan 82
CO - Colombia 65
LT - Lituania 58
MA - Marocco 57
VE - Venezuela 55
SA - Arabia Saudita 53
IE - Irlanda 52
MY - Malesia 51
PH - Filippine 48
UZ - Uzbekistan 46
CL - Cile 45
CZ - Repubblica Ceca 38
PY - Paraguay 38
TN - Tunisia 37
AT - Austria 36
AE - Emirati Arabi Uniti 33
NP - Nepal 28
JM - Giamaica 27
EG - Egitto 26
KE - Kenya 25
UY - Uruguay 24
JO - Giordania 23
PE - Perù 22
AU - Australia 20
AZ - Azerbaigian 20
IR - Iran 20
DZ - Algeria 18
AL - Albania 17
CH - Svizzera 17
IL - Israele 16
KR - Corea 16
HN - Honduras 15
BO - Bolivia 13
TT - Trinidad e Tobago 13
DO - Repubblica Dominicana 12
RO - Romania 12
TH - Thailandia 12
LB - Libano 11
BG - Bulgaria 10
SN - Senegal 10
ET - Etiopia 9
MD - Moldavia 9
NZ - Nuova Zelanda 9
PA - Panama 9
BH - Bahrain 8
CR - Costa Rica 8
GR - Grecia 8
PT - Portogallo 8
SV - El Salvador 8
TW - Taiwan 8
DK - Danimarca 7
GT - Guatemala 7
HR - Croazia 7
KZ - Kazakistan 7
NG - Nigeria 7
NI - Nicaragua 7
RS - Serbia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CY - Cipro 6
GY - Guiana 6
NO - Norvegia 6
EU - Europa 5
GD - Grenada 5
LV - Lettonia 5
OM - Oman 5
PS - Palestinian Territory 5
AM - Armenia 4
KG - Kirghizistan 4
KH - Cambogia 4
LK - Sri Lanka 4
LU - Lussemburgo 4
Totale 63.012
Salva come PNG Salva come JPEG
Città #
Ashburn 4.099
Singapore 3.816
Fairfield 3.307
Woodbridge 2.892
Houston 2.008
San Jose 1.972
Jacksonville 1.598
Ann Arbor 1.518
Chandler 1.393
Seattle 1.370
Dallas 1.289
Santa Clara 1.266
Beijing 1.221
Hong Kong 1.203
Wilmington 1.182
Cambridge 1.156
Council Bluffs 682
Munich 617
Los Angeles 592
New York 586
Ho Chi Minh City 579
Izmir 548
Nanjing 457
Hanoi 371
Princeton 356
Tokyo 341
Ferrara 334
Helsinki 318
Lauterbourg 308
San Diego 290
Boardman 265
Milan 264
Shanghai 212
São Paulo 202
Warsaw 195
London 153
Nanchang 139
Orem 138
Brooklyn 133
Shenyang 129
Dearborn 128
Turku 128
Mexico City 122
Toronto 122
Montreal 119
Atlanta 114
Denver 114
Falkenstein 109
Chicago 107
Tianjin 105
Hefei 103
Buffalo 101
Frankfurt am Main 100
Jakarta 99
Phoenix 97
Da Nang 94
The Dalles 93
Falls Church 92
San Francisco 86
Brussels 85
Hebei 81
San Mateo 81
Moscow 79
Norwalk 78
Jiaxing 75
Bremen 74
Johannesburg 74
Changsha 70
Chennai 69
Boston 67
Rio de Janeiro 65
Mountain View 64
Redwood City 64
Haiphong 62
Jinan 59
Stockholm 59
Bologna 57
Guangzhou 53
Washington 53
Manchester 52
Philadelphia 52
Dublin 50
Rome 49
Addison 48
Auburn Hills 48
Dhaka 46
Amsterdam 45
Dong Ket 45
Baghdad 44
Kunming 44
Zhengzhou 44
Mumbai 43
Poplar 42
Tashkent 42
Belo Horizonte 38
Ankara 36
Hải Dương 34
Columbus 33
Lahore 33
Naples 31
Totale 43.800
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.251
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 998
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 399
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 381
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 345
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 341
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 323
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 310
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 303
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 297
A new selective antagonist of the nociceptin receptor 282
Effects of vasoactive agents in healthy and diseased human saphenous veins 280
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 280
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 274
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 272
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 271
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 270
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 270
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 267
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 265
A new ligand for the urotensin II receptor 260
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 259
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 256
The effect of guanethidine and local anaesthetics on the electrically stimulated mouse vas deferens 250
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 249
Actual concept of "probiotics": is it more functional to science or business? 247
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 247
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 246
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 246
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 245
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 245
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 244
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 242
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 240
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 240
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 240
A simple method for electrical field stimulation of cultured granule cells 240
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 240
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 237
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 237
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 236
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 234
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 234
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 233
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 233
Cardiovascular effects of nociceptin in unanesthetized mice 232
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 232
Modulation of the NOP receptor signaling affects resilience to acute stress 232
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 232
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 232
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 231
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 230
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 230
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 228
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 228
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 228
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 225
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation 225
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 222
Neuropeptide S receptor ligands: a patent review (2005-2016) 222
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 221
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 221
Pharmacological characterisation of novel kinin B2 receptor ligands 221
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 221
Pharmacological characterization of tachykinin tetrabranched derivatives 221
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 220
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 220
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 220
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 219
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 219
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 218
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 218
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 218
B1 and B2 kinin receptors in various species 215
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 215
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 214
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 213
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 213
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 213
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 213
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 212
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 210
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 209
Sudden death from pulmonary thromboembolism: chronobiological aspects 208
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 208
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 208
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 208
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 207
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 207
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 207
Pharmacological characterization of nociceptin receptor: an in vitro study 207
null 205
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 204
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 204
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 204
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 204
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 203
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 203
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 203
Totale 25.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 283.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.021
Totale 288.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.500 0 369 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.783 196 229 88 50 99 310 74 142 35 30 53 477
2024/20257.710 184 203 632 256 875 769 271 496 1.226 795 1.075 928
2025/202622.595 2.223 1.107 2.409 2.779 3.039 1.412 2.592 1.114 1.963 2.327 1.002 628
2026/20272.581 1.706 875 0 0 0 0 0 0 0 0 0 0
Totale 63.607